{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:59:20Z","timestamp":1793642360623,"version":"4.5.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.pnpbp.2010.02.027","type":"journal-article","created":{"date-parts":[[2010,3,4]],"date-time":"2010-03-04T09:41:04Z","timestamp":1267695664000},"page":"819-821","source":"Crossref","is-referenced-by-count":73,"title":["Increased uric acid levels in drug-na\u00efve subjects with bipolar disorder during a first manic episode"],"prefix":"10.1016","volume":"34","author":[{"given":"Giacomo","family":"Salvadore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos I.","family":"Viale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Luckenbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa C.","family":"Zanatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz V.","family":"Portela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo O.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Carlos A.","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Machado-Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2010.02.027_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/j.1399-5618.2006.00363.x","article-title":"Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial","volume":"8","author":"Akhondzadeh","year":"2006","journal-title":"Bipolar Disord"},{"issue":"7555","key":"10.1016\/j.pnpbp.2010.02.027_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(68)92300-3","article-title":"Uric-acid metabolism in manic-depressive illness and during lithium therapy","volume":"1","author":"Anumonye","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2010.02.027_bib3","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-2010-1330","article-title":"Uric acid as a central nervous system antioxidant","author":"Bowman","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"10.1016\/j.pnpbp.2010.02.027_bib4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrd2605","article-title":"Purinergic signalling and disorders of the central nervous system.","volume":"7","author":"Burnstock","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.pnpbp.2010.02.027_bib5","first-page":"195","article-title":"Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder","volume":"22","author":"De Berardis","year":"2008","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.pnpbp.2010.02.027_bib6","series-title":"Structured clinical interview for the DSM-IV-TR Axis I disorders \u2014 patient edition","author":"First","year":"2002"},{"key":"10.1016\/j.pnpbp.2010.02.027_bib7","series-title":"Structured clinical interview for DSM-IV-TR Axis I disorders, research version, non-patient edition","author":"First","year":"2002"},{"issue":"3-4","key":"10.1016\/j.pnpbp.2010.02.027_bib8","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.002543","article-title":"Lesch\u2013Nyhan disease: from mechanism to model and back again","volume":"2","author":"Jinnah","year":"2009","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.pnpbp.2010.02.027_bib9","series-title":"Manic\u2013depressive insanity and paranoia","author":"Kraeplin","year":"1921"},{"key":"10.1016\/j.pnpbp.2010.02.027_bib10","article-title":"Association of serum uric acid levels with emotional and affective temperaments","author":"Lorenzi","year":"2009","journal-title":"J Affect Disord"},{"issue":"6","key":"10.1016\/j.pnpbp.2010.02.027_bib11","doi-asserted-by":"crossref","DOI":"10.1097\/00004714-200112000-00017","article-title":"Therapeutic efficacy of allopurinol in mania associated with hyperuricemia","volume":"21","author":"Machado-Vieira","year":"2001","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.pnpbp.2010.02.027_bib12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1054\/mehy.2001.1543","article-title":"Purinergic dysfunction in mania: an integrative model","volume":"58","author":"Machado-Vieira","year":"2002","journal-title":"Med Hypotheses"},{"issue":"8","key":"10.1016\/j.pnpbp.2010.02.027_bib13","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.v69n0806","article-title":"A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2010.02.027_bib14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/mp.2008.6","article-title":"Case-control studies show that a non-conservative amino-acid change from a glutamine to arginine in the P2RX7 purinergic receptor protein is associated with both bipolar- and unipolar-affective disorders","volume":"14","author":"McQuillin","year":"2009","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2010.02.027_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0920-1211(91)90070-V","article-title":"Plasma uric acid levels in patients receiving anticonvulsant monotherapy","volume":"8","author":"Ring","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pnpbp.2010.02.027_bib16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2010.02.027_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/msj.20042","article-title":"Bipolar disorder: candidate drug targets","volume":"75","author":"Zarate","year":"2008","journal-title":"Mt Sinai J Med"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584610000746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584610000746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,26]],"date-time":"2019-05-26T12:32:48Z","timestamp":1558873968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584610000746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0278584610000746"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2010.02.027","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}